期刊文献+

广州市海珠区肺结核病人的耐药性监测 被引量:5

Monitoring of initial drag resistant status in patients with puhnonary tuberculosis in Haizhu District of Guangzhou City
下载PDF
导出
摘要 目的 监测肺结核菌阳性病人的起始耐药情况,评价抗痨效果和结核病控制现状。方法 按DOTS方案进行药敏试验,监测新发病例痰培养结核菌阳性的抗痨药物敏感性。结果1996~2001年每年起始耐药率在10.9%~30.4%范围内.平均起始耐药率为21.5%(105/489);70~岁组起始耐药率最低(10.5%),50~岁组起始耐药率最高(27.1%)。异烟肼(H)、利福平(R)、链霉素(S)、乙胺丁醇(E)的耐药率依次为:H>S>R=E,以H耐药率最高17.8%(87/489);而同时以H、R、E、S的4种药物耐药率仅为1.0%(5/489)。结论 临床抗痨药物耐药情况严重,建议使用抗结核复合剂,严格DOTS治疗,以降低结核病耐药并控制结核病。 Objective To investigate the initial drug-resistance in patients with pulmonary tuberculosis in Haizhu District and evaluate the effectiveness of tuberculosis control work in this district. Methods The detection of resistance to anti - tuberculosis drugs was carried out based on WHO recommended Dots treatment for monitoring the sensitivity of the tubercle bacillus form smear - positive samples to antibiotics. Results The initial resistant rate in 1996-2001 was in the rang of 10.9%-30.4%,average21.5%(105/ 489).The rate of initial resistance in the age group of 70- was lower( 10.5%) and it was higher in the age group of 50 ~ (27.1%). The drug resistance was in the order of hydrazide (H) > streptomycin(S) > rifampicin( R) = ethambutol(E), being 17.8 % to H, ( 87/ 489). It was observed that the resistance to four combined use of antibiotics of HRES was the lowest, being 1.0% (5/489) . Conclusion The resistance of tubercle bacillus to antibiotics is getting serious and compound anti - tuberculosis drug be developed to tackle the resistant problems in addition to standardize the treatment of WHO recommended DOTS in order to elongate the development of the resistance and control the disease.
出处 《中国热带医学》 CAS 2002年第3期390-392,共3页 China Tropical Medicine
关键词 疾病控制 广州 海珠区 肺结核 耐药性监测 Drug-resistance Tuberculosis Monitoring Control.
  • 相关文献

参考文献5

二级参考文献10

共引文献166

同被引文献131

  • 1张立兴.中国结核病控制工作面临的挑战[J].中华流行病学杂志,2004,25(8):645-646. 被引量:42
  • 2范素莲,卫风谦,郭磊,高炳田,江振英,高建彬,李伟.初治肺结核212例耐药性测定[J].中国防痨杂志,1995,17(3):128-129. 被引量:15
  • 3戴元生,池延花,杜昕,苏智,李凤茹,王克文,邹级谦,赵丰曾.世行贷款项目省结核病控制实施水平不均衡性及其影响因素评析[J].中国防痨杂志,1997,19(1):6-10. 被引量:62
  • 4何宗宁 张仲扬 张素芳 等.512株结核菌耐药试验及297株分支杆菌菌型鉴定结果分析[J].中国防痨通讯,1987,9(1):7-8.
  • 5Havlir DV,Duble MP,Satter FR.Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin,daily rifabutin,or both N Engi[J].J Med,1996;335:392-8
  • 6Benson CA,Cohn DL,Williams P.For the ACTG 196/CPCRA 009 Study efficacy of clarithromycin(CLA) vs.rifabutin(RBT)vsCLA+RBT for prevention of Mycobacterim avium complex(MAC) disease inHIV+ patients with CD4 counts≤100 cells·μl-1[R].(Abstr.205) 3rd Conference on Retroviruses and Opportunistic Infections.Washington,DC,1996
  • 7Scampini G,Nava A,Newsman AJ,Della-Torre P,Mazue G.Multinucleated hepatocytes induced by rifabutin in rats[J].Toxicol Pathol,1993;21:369-76
  • 8Hellinger FJ.The lifetime cost of treating a person with HIV[J].JAMA,1993;270:474-8
  • 9Moore RD,Keruly JC,Chaisson RE.Costs of treating HIV disease under medicaid in maryland[J].J Acquir immune Defic Syndr Hum Retrovirol,1997;14:223-31
  • 10Gable CB,Tierce JC,Simison D,Ward D,Motte K.Costs of HIV+/AIDS at CD4+counts disease stages based on treatment protocols[J].J Acquir Immune Defic Syndr Hum Retrovirol,1996;12:413-20

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部